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Abstract
 
The human gastric pathogen 
 
Helicobacter pylori
 
 spontaneously switches lipopolysaccharide (LPS)
Lewis (Le) antigens on and off (phase-variable expression), but the biological significance of
this is unclear. Here, we report that Le
 
  
 
H. pylori
 
 variants are able to bind to the C-type lectin
DC-SIGN and present on gastric dendritic cells (DCs), and demonstrate that this interaction
blocks T helper cell (Th)1 development. In contrast, Le
 
  
 
variants escape binding to DCs and
induce a strong Th1 cell response. In addition, in gastric biopsies challenged ex vivo with Le
 
 
 
variants that bind DC-SIGN, interleukin 6 production is decreased, indicative of increased
immune suppression. Our data indicate a role for LPS phase variation and Le antigen expres-
sion by 
 
H. pylori
 
 in suppressing immune responses through DC-SIGN.
Key words:
 
Helicobacter pylori
 
 • phase variation • DC-SIGN • dendritic cells • 
Th1/Th2 cell response
 
Introduction
 
The human Gram-negative bacterium 
 
Helicobacter pylori
 
 is
able to persist for a lifetime on the gastric mucosa of 50% of
the world population. In most individuals, colonization results
in uncomplicated chronic gastritis, but in some patients 
 
H.
pylori
 
 infection leads to gastric and duodenal ulcers, mucosa-
associated lymphoid tissue lymphoma, and adenocarcinoma
(1, 2). To date, the mechanism(s) that enables 
 
H. pylori
 
 to
adapt to a large variety of genetically diverse hosts is unknown.
Most 
 
H. pylori
 
 express O-antigen Lewis (Le) blood
group antigens in their LPS (Le
 
x
 
, Le
 
y
 
, H type 1, Le
 
a
 
, Le
 
b
 
,
i-antigen, and sialyl Le
 
x
 
; for carbohydrate structure see Fig.
2 A; references 3–8). This restricted diversity in O-antigenic
structures suggests a role for Le antigens in 
 
H. pylori
 
 infec-
tion. Le
 
x/y 
 
expression is not a stable trait, but is subjected to
phase variation (i.e., the occurrence of spontaneous, high
frequency [up to 0.5%], reversible on and off switching of
LPS epitopes), resulting in Le
 
x
 
 
 
/Le
 
y
 
  
 
and Le
 
x
 
 
 
/Le
 
y
 
  
 
bacteria
within a single strain (9). Le phase variation in 
 
H. pylori
 
 is
caused by translational frame shifts in glycosyltransferase
genes that occur during replication (10). Similar mecha-
nisms of phase variation in 
 
Neisseria
 
 ssp. (11) and 
 
Haemophilus
influenzae 
 
(12) have been described. These mechanisms
have resulted in microorganisms that either adhere better to
host cells or are more resistant to killing by complement
(13). The role of Le antigens in adhesion to the gastric epi-
thelium has been explored and the most recent data indi-
cate that expression of Le
 
x 
 
only plays a minor role in adher-
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ence of 
 
H. pylori
 
 to the gastric mucosa (14-16). Expression
of Le antigens by 
 
H. pylori
 
 has been implicated in evasion
of the host immune system by mimicking blood group an-
tigens expressed on the gastric mucosa (17), but here con-
troversial findings have also been reported (18). Further-
more, a correlation between Le expression and the degree
of leukocyte infiltration (18) and that of symptomatic in-
fection (19) has been described. However, expression of Le
antigens is phase variable, resulting in several Le
 
  
 
and Le
 
 
 
populations of 
 
H. pylori
 
 within a single strain. Therefore,
the above mentioned studies may reflect the host response
to heterogeneous populations of 
 
H. pylori
 
 Le
 
  
 
and Le
 
 
 
phase variants, leaving the interpretation of these findings
rather difficult. So far, the biological roles of Le antigen ex-
pression and phase variation remain unclear.
 
H. pylori
 
 infection is marked by rapid recruitment of
neutrophils followed by T and B lymphocytes, plasma cells,
and macrophages (20). T lymphocyte responses in acute 
 
H.
pylori
 
 infection are predominantly of the CD4
 
  
 
Th1 cell
phenotype (21), but data regarding accessory cells involved
in presentation of 
 
H. pylori
 
 antigens to T cells are scarce.
Despite their evident importance as link between innate
and adaptive immunity, little attention has been paid to the
role of DCs in 
 
H. pylori
 
 infection. Immature DCs are
seeded throughout peripheral tissues and along mucosal
surfaces to act as sentinels, and upon pathogen capture DCs
are activated. Activated DCs process pathogens into anti-
genic peptides for presentation and migrate to secondary
lymphoid organs where they activate naive T cells and steer
adaptive T cell responses (22).
DCs express the C-type lectin DC-SIGN, which is in-
volved in cell adhesion as well as antigen presentation to T
cells (23). Accumulating evidence indicate DC-SIGN as
pathogen receptor for viruses, parasites, fungi, and bacteria
(24–27), including 
 
H. pylori
 
 (28). Binding to the carbohy-
drate recognition domain of DC-SIGN is dependent on
high mannoses or Le sugars. The described phase variation
of LPS Le antigens prompted us to analyze binding of 
 
H.
pylori
 
 variants to DCs and the functional consequence of
binding and the role of DC-SIGN herein. Here, we dem-
onstrate that 
 
H. pylori
 
 LPS phase variation occurs in vivo
and that clinically isolated Le
 
 
 
, but not Le
 
 
 
, phase variants
can bind to DC-SIGN, which is present on DCs in gastric
mucosa. This interaction has direct consequences on Th1/
Th2 cell polarization.
 
Materials and Methods
 
Bacterial Strains. H.  pylori
 
 clinical isolates of different geo-
graphic origins (Netherlands, Canada, Poland, Italy, and China)
have been described (5), as well as 
 
H. pylori
 
 strain NCTC 11637
and phase variants 1c, K4.1, K5.1, 3a, and 1b (9). 
 
H. pylori
 
 strain
4187E and generation of 
 
futA
 
 (gene HP0379) and 
 
futB
 
 (gene
HP0651) knockout mutants have been described (10). LPS was pu-
rified by the hot-phenol-water procedure followed by gel-perme-
ation chromatography (6). Clinical isolate 
 
H. pylori
 
 J223 was as de-
scribed previously (6). Le
 
x/y
 
  
 
and Le
 
x/y
 
  
 
variants of J223 were
isolated as described previously (9). In brief, bacteria from the bi-
opsy were inoculated on Dent plates (Columbia agar, 5% horse
blood, plus Dent supplement), followed by one single passage in
fluid phase (Brucella broth plus 3% FCS) and distribution over solid
media, after which detection of LPS phase variants was performed
by colony blotting (9). Genotyping by amplified fragment length
polymorphism (AFLP) analysis was performed as described (29)
with the following modifications. In a final volume of 20 
 
 
 
l, 20 ng
of purified chromosomal DNA was digested with 1 U EcoRI (BD
Biosciences) and 1 U MseI (New England Biolabs, Inc.). The final
volume then was increased to 30 
 
 
 
l by the addition of 50 pmol
each of the EcoRI adaptor and MseI adaptor, 1.2 U of T4 DNA li-
gase (BD Biosciences), 1 mM ATP, and ligase buffer. The adaptors
were allowed to ligate to the restriction fragments for 16 h at
167
 
 
 
C, after which the sample was diluted with distilled water in a
final volume of 50 
 
 
 
l. Texas red fluorescent-labeled EcoO primer
(5
 
 
 
-AGACTGCGTACCAATTC-3
 
 
 
; Isogen Bioscience) and un-
labeled MseO primer (5
 
 
 
-GACGATGAGTCCTGAG-3
 
 
 
) were
used for DNA amplification in a thermal cycler (GeneAmp PCR
system 9700; PerkinElmer) with 35 cycles as follows: denaturation
(30 s at 94
 
 
 
C), annealing (30 s at 65–56
 
 
 
C), and DNA molecule
extension (60 s at 72
 
 
 
C). In the first 12 cycles, the annealing tem-
perature was lowered 0.7
 
 
 
C per cycle. After completion of the cy-
cle program, each sample was analyzed according to the manufac-
turer’s instructions in an automated DNA sequencer (Vistra 725;
Amersham Biosciences). Fluorescent AFLP images were stored as
TIFF files with TIFF software (Vistra 2; Amersham Biosciences).
C-tract sequencing was performed as described previously (10).
 
mAbs and Glycoconjugates. H. pylori
 
 strains and phase variants
were serotyped as described previously (5) with the following
mAbs: Hp151, specific for Le
 
y
 
; 6H3, specific for monomeric Le
 
x
 
;
4D2, specific for H type 1 (all three provided by R. Negrini,
General Hospital, Brescia, Italy); 54.1F6A, specific for polymeric
Le
 
x 
 
(provided by G. van Dam, Leiden University, Leiden, Neth-
erlands); and NAM61-1A2, specific for i antigen (provided by D.
Blanchard, Regional Blood Transfusion Service, Nantes, France;
reference 10). mAbs AZN-D1 and AZN-D2 (24) were used to
block DC-SIGN and mAb Clone 17 (provided by S. Gordon,
University of Oxford, Oxford, UK) was used to block the
mannose receptor (MR). Synthetic glycoconjugates (Syntesome)
comprised monosaccharides and oligosaccharides that were mul-
tivalently linked to a polyacrylamide carrier. Ceramide-linked
dimeric, trimeric, and tetrameric Le
 
x 
 
antigens were provided by
R.R. Schmidt (University of Konstanz, Konstanz, Germany) and
synthesized as described previously (30).
 
Cells.
 
Immature DCs were generated by culturing mono-
cytes in RPMI 1640/10% FCS in the presence of 500 U/ml IL-4
and 800 U/ml GM-CSF (both from Schering-Plough) for 5–8 d
(31). K-562 cells, K-562-DC-SIGN cells, and RAW 264.7 mac-
rophages were cultured as described previously (31).
 
Bacterial Binding. H.  pylori
 
 cells were labeled with FITC.
50,000 cells in Tris-saline-magnesium buffer with 0.5% BSA
were preincubated with 20 
 
 
 
g/ml mAb, 200 
 
 
 
g/ml mannan, or
10 mM EDTA for 10 min at room temperature. FITC-labeled
bacteria (10 bacteria/cell) were added and incubated for 45 min
at 37
 
 
 
C. Samples were analyzed by flow cytometry.
 
Soluble DC-SIGN-Fc Adhesion Assay.
 
The soluble DC-SIGN
adhesion assay was performed by ELISA (32). Antigens (either
3.75 
 
  
 
10
 
6 
 
bacterial cells/well or 5 
 
 
 
g/ml in the case of LPS or
glycoconjugates) were coated in ELISA plates. Soluble DC-
SIGN-Fc (1 
 
 
 
g/ml in Tris-saline-magnesium buffer) binding was
determined by an anti–human Ig-Fc ELISA. When indicated,
DC-SIGN-Fc was preincubated with 20 
 
 
 
g/ml mAb, 200 
 
 
 
g/
ml mannan, or 5 mM EDTA for 10 min at room temperature. 
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Immunohistochemistry.
 
After informed consent by the patients,
two antral biopsies were collected during gastroscopy. Tissue
cryosections were fixed in acetone and incubated with AZN-D1
followed by anti–mouse horseradish peroxidase. Staining was
performed with the ABC-AP Vectastain kit and AEC (Vector
Laboratories), and sections were counterstained with hematoxy-
lin. In parallel, the other biopsy was analyzed for 
 
H. pylori
 
 infec-
tion by incubation in urease medium for 12 h. No differences in
morphology and staining were observed between noninfected
and infected individuals.
 
DC Activation and Th1/Th2 Cell Differentiation.
 
To analyze
maturation, 180,000 DCs were incubated with 
 
H. pylori
 
 for 1 h at
multiplicities of infection (MOIs) of 1, 5, 10, and 20, and washed
and cultured for 20 h. Cells were analyzed for maturation mark-
ers (CD80, CD86, CD83, and HLA-DR) by flow cytometry,
and supernatant was collected for cytokine ELISA (27).
For T cell differentiation, DCs were cocultured with 
 
H. pylori
 
(at an MOI of 10) for 2 d, washed, and incubated with CD45RA
 
 
 
CD4
 
  
 
T cells (5,000 T cells/20,000 DCs). In parallel, DCs were
analyzed for the maturation markers described above and cytokine
production after stimulation with J558 transfected with CD40L
(provided by P. Lane, University of Birmingham, Birmingham,
UK) in the presence or absence of 1,000 U/ml IFN-
 
 
 
.
Quiescent T cells were restimulated with 10 ng/ml PMA and
1 
 
 
 
g/ml ionomycin for 6 h. During the last 5 h of that time, they
were in the presence of 10 
 
 
 
g/ml brefeldin A (all from Sigma-
Aldrich). Single cell production of IL-4 and IFN-
 
  
 
was deter-
mined by intracellular flow cytometry (33).
 
Patients and Ex Vivo Challenge of Biopsies with H. pylori.
 
11
patients attending the Endoscopy Unit of the Outpatient Clinic of
Gastroenterology of the Vrije Universiteit Medical Center, who
were referred for diagnostic gastroscopy, were invited to participate
in this investigation. Each patient provided informed consent in
agreement with the Declaration of Helsinki to obtain two biopsy
specimens additional to the clinically indicated biopsy specimens.
The biopsy specimens used in these experiments were collected dur-
ing two mornings in which the endoscopies were performed. Biop-
sies were cultured with 10 
 
  
 
10
 
6 
 
H. pylori
 
 for 48 h. Supernatant was
collected and the biopsies were homogenized using a polytron. Ho-
mogenates and supernatants from nine patients who were shown to
be negative for 
 
H. pylori
 
 by histology/immunohistochemistry, as
scored by an experienced pathologist, were tested for the presence of
IL-4, IL-6, IL-10, IL-12p40, IL-12p70, and IFN-  by ELISA.
Results
DC-SIGN Is a Receptor for H. pylori and Binding of H.
pylori to DC-SIGN Occurs via LPS. DC-SIGN binds Lex
and Ley (28), so we investigated whether DC-SIGN func-
tions as a receptor for H. pylori. Several clinical isolates of
H. pylori from different continents (5) did bind to DC-
SIGN fusion protein, which suggests that the H. pylori cell
wall contains a common and universal ligand for DC-
SIGN (Fig. 1). H. pylori binds DC-SIGN through its LPS,
as was indicated by the binding of several batches of puri-
fied H. pylori LPS to DC-SIGN (Fig. 1). For 11 H. pylori
strains, both whole bacterial cells and purified LPS were
available, and the binding to DC-SIGN of whole cells and
purified LPS correlates well (r   0.8045; P   0.0028; 95%
confidence interval of 0.39–0.95; not depicted). The bind-
ing of H. pylori whole cells or purified LPS to DC-SIGN-
Fc could be blocked by anti–DC-SIGN antibodies with
mannan, or by chelating free Ca2  ions with EGTA (not
depicted), indicating that binding was specific.
H. pylori LPS Binds DC-SIGN through Le Antigens. Be-
cause DC-SIGN binds carbohydrates, LPS Le antigens might
be involved in the binding of H. pylori to DC-SIGN. The
binding of synthetic blood group antigens to soluble DC-
SIGN was studied. Lex and Ley bound to DC-SIGN (Fig. 2
B), confirming previous results (28, 34), as did Lea and Leb
(not depicted). Surprisingly, H type 2, but not H type 1,
bound to DC-SIGN (Fig. 2 B), even though these carbohy-
drate structures comprise identical monosaccharides, as they
are linked at a different position (Fig. 2 A). In H. pylori LPS,
Lex can be present in a polymeric form, i.e., repetitive copies
of single (monomeric) Lex (up to n   8–9) in a long chain.
Polymeric Ley  does not exist. Although monomeric Lex
strongly bound to DC-SIGN, binding surprisingly decreased
with an increasing number of copies of Lex (Fig. 2 C). Next,
substructures of Le carbohydrates were tested for binding to
DC-SIGN. First, single sugar residues were tested. l-fucose,
but not d-galactose or N-acetyl-d-glucosamine, bound to
DC-SIGN (Fig. 2 B). Moreover, fucose-containing disac-
charides were analyzed to determine the substructure to
which DC-SIGN binds (Fig. 2 B). Of the disaccharides stud-
ied, Fuc 1-4GlcNAc (present on Ley) and, strikingly, Fuc 1-
2Gal  (shared by Ley, Leb, and H type 1; Fig. 2 A) also bound
to DC-SIGN. Thus, although complete Le H type 1 did not
bind to DC-SIGN, its substructure-containing fucose did
bind. Hence, H. pylori binds DC-SIGN through Le antigens,
but the steric organization of the sugar residues involved in
the interaction with DC-SIGN is also important.
Binding of H. pylori to DC-SIGN Requires Functional
Expression of Bacterial  3-Fucosyltransferase Genes. Biosynthe-
sis of Lex/y antigens is dependent on the function of  3-
Figure 1. Clinically isolated H. pylori and purified LPS bind to DC-
SIGN. H. pylori strains ( ) isolated from patients from different conti-
nents (reference 5) and purified LPS ( ) were coated on ELISA plates,
and binding of recombinant DC-SIGN-Fc was assessed with peroxidase-
labeled goat anti–human Fc.H. pylori Phase Variants Inhibit Th1 Cell Responses through DC-SIGN 982
fucosyltransferases FutA and FutB (10). We used H. pylori
4187E, its subsequent futA and futB mutants, and the futA/
futB double knockout (10) to test our hypothesis that DC-
SIGN binding to H. pylori cells is Lex/y dependent. Inter-
ruption of futA does not affect expression of mono Lex/y,
whereas interruption of futB results in predominant expres-
sion of polymeric Lex only (Fig. 3 A). Disruption of both
futA and futB yields mutants that almost completely lack Le
expression (Fig. 3 A). Indeed, we found that although
4187E (that expresses Lex/y) did bind to DC-SIGN, futB
and futA/B mutants that were disabled for expression of Ley
and monomeric Lex did not bind to DC-SIGN (Fig. 3 A).
Next, natural H. pylori strains with Lex/y serotypes corre-
sponding to that of the 4187E futA/futB mutant strains
Figure 2. Le blood group and
related antigens and some of
their substructures bind to DC-
SIGN. (A) Le antigens expressed
by H. pylori and discussed in this
paper. (B and C) Carbohydrates,
representing blood group antigens
or their substructures, conju-
gated to polyacrylamide (B) or
ceramide (C), were coated and
binding of recombinant DC-
SIGN-Fc was measured after in-
cubation with peroxidase-labeled
goat anti–human Fc. The mean
(  SD) of three independent ex-
periments is shown.
Figure 3. Binding of H. pylori
is dependent on Le antigen ex-
pression. (A–C) H. pylori  3-fuco-
syltransferase mutants (A), strains
(B), and phase variants (C) were
coated, and binding of recombi-
nant DC-SIGN-Fc was measured
after incubation with peroxidase-
labeled goat anti–human Fc. H.
pylori were coated and incubated
with mAbs specific for Le anti-
gens indicated, and their sero-
type was determined after incu-
bation with peroxidase-labeled
anti–mouse Igs. The mean (  SD)
of three independent experiments
is shown.Bergman et al. 983
were tested for binding to DC-SIGN. Strain NCTC 11637
(4) resembles the 4187E futB mutant by the predominant
expression of polymeric Lex  and as expected, LPS of
NCTC 11637 did not bind to DC-SIGN (Fig. 3 B). H. py-
lori strains MO19, O:6, and P466 (3, 35), which represent
the 4187E futA mutant phenotype and strongly express Ley,
were all able to bind to DC-SIGN. We concluded that the
binding of H. pylori to DC-SIGN depends on the expres-
sion of monomeric Lex and Ley, but not polymeric Lex.
LPS Le Antigenic Phase Variation In Vitro within a Single
Strain of H. pylori Affects Binding to DC-SIGN. In a single
H. pylori strain, reversible on-off switching of fucosyltrans-
ferases regulates the expression of Le antigens. This so-
called phase variation results in Lex/y  and Lex/y  bacteria
within a single strain (9). Several LPS phase variants of
NCTC 11637, which can be distinguished serologically,
were tested for their binding to DC-SIGN (Fig. 3 C). As
described above, LPS from NCTC 11637 expresses poly-
meric Lex only and did not bind to DC-SIGN (Fig. 2 C).
LPS phase variants 1b and 1c, which during in vitro culture
have turned on Ley expression, did bind to DC-SIGN (Fig.
3 C). In contrast, variants K4.1 and K5.1, which represent
a switch back to the parental serotype and thus lack expres-
sion of Ley and monomeric Lex, did not bind to DC-SIGN
(Fig. 3 C). Thus, the ability of NCTC 11637 to bind to
DC-SIGN is regulated by phase variation during in vitro
culture, i.e., on-off switching of Le antigen expression.
H. pylori LPS Phase Variation Drives Strain Diversification
In Vivo, and Only Lex/y  Variants of a Clinical Isolate Bind to
DC-SIGN. Phase variation in the host might determine
the binding of H. pylori to DC-SIGN on DCs, but to date
there is no evidence that phase variation occurs in vivo.
We used a clinical isolate, H. pylori J223 (6), to demonstrate
phase variation in the host. Chemical analysis previously
revealed that J223 lacks expression of Lex/y (6), predicting
that these bacteria do not bind to DC-SIGN, which indeed
was the case (not depicted). However, in primary cultures
from the biopsy, two variants of J223 could be detected by
colony blotting in a ratio that could not result from in
vitro phase variation during primary culture, as was con-
cluded from the calculated frequencies of phase variation
( 0.35%) and the time span of the experiment. This indi-
cates that the two variants are derived from in vivo phase
variation, i.e., phase variation has occurred in the stomach
of the host. The predominant variant, J223.8, resembled
the parent strain J223 and lacked expression of monomeric
Lex and Ley, whereas the second variant, J223.3, did express
Ley (Fig. 4 A). Sequencing of the  3-fucT gene C-tracts
showed that both genes futA and futB are switched off in
J223.8, but that futB was functionally expressed in variant
J223.3, which is in agreement with the Le expression of
these variants (Fig. 4 A). Interruption of futB in variant
J223.3 resulted in a phenotype identical to that of variant
J223.8 lacking Le antigens (Fig. 4 A), and switches from
J223.3 to J223.8 and vice versa were observed on plate in
vitro (not depicted). In addition, AFLP analysis revealed
96% homology between J223.3 and J223.8 that were cul-
tured directly from the gastric biopsy, confirming that these
variants are isogenic and not derived from two different
strains (not depicted). Next, DC-SIGN binding of these
two variants was analyzed (Fig. 3 C). Variant J223.3 was
able to bind DC-SIGN, whereas J223.8 was not. Hence,
we demonstrated that LPS phase variation in H. pylori oc-
curs in vivo and yields populations that either bind DC-
SIGN via Ley or escape binding to DC-SIGN by switching
off Le expression.
DCs Are Present in the Lamina Propria of the Stomach and
Express DC-SIGN. The binding of clinically isolated
strains of H. pylori to soluble DC-SIGN indicates a possible
function for this DC-specific pathogen receptor in vivo.
Here, we demonstrate that DC-SIGN–expressing cells
with a DC-like morphology were detected in the lamina
propria of the stomach (Fig. 5 A, arrows). The distribution
or number of DC-SIGN–expressing cells in H. pylori–infected
Figure 4. LPS phase variation
in H. pylori occurs in vivo. (A)
After a short time of culturing
directly from the biopsy, fol-
lowed by one single passage in
fluid phase and distribution over
solid media, Lex/y  phase variants
of J223 were detected by colony
blotting with mAbs specific for
the indicated Le antigens. C-tract
sequencing was performed to
determine the on and off status
of genes futA (HP0379) and futB
(HP0651). The J223.3 futB mu-
tant was generated by natural
transformation with construct
containing a chloramphenicol
resistance marker cassette inserted
in gene HP0651, and serotyped as
indicated for J223. (B) Conse-
quences of the C-tract length for
functional expression of futA and
futB.H. pylori Phase Variants Inhibit Th1 Cell Responses through DC-SIGN 984
individuals was not different from that observed in non-
infected persons (not depicted). Interestingly, several DC-
SIGN  cells were located directly beneath the stomach
epithelial cell layer. Considering the ability of DCs to pro-
trude into the intestinal lumen by penetrating the epithelial
cell layer (36), our results implicate that DC-SIGN–express-
ing DCs are situated in close proximity to the stomach lu-
men and could be involved in H. pylori capture in vivo.
DC-SIGN Is a Major Receptor on DCs for Lex/y  H. pylori,
whereas Lex/y  Isogenic Phase Variants Escape Binding. To
demonstrate that DC-SIGN–expressing cells could capture
Lex/y  H. pylori, we generated monocyte-derived DCs ex-
pressing DC-SIGN and studied their interaction with
J223.3 and J223.8. Interestingly, the Ley  variant J223.3
strongly bound to DCs, whereas J223.8 did not (Fig. 5 B).
Preincubation of DCs with blocking antibodies against
DC-SIGN or MR demonstrated that DC-SIGN was a ma-
jor receptor for J223.3 H. pylori on DCs, whereas a part of
J223.3 was bound by the C-type lectin MR (Fig. 5 C).
These results are consistent with a recent study showing
that Le clusters are specifically targeted to DC-SIGN, rather
than MR (37). Macrophages lacking DC-SIGN bound
J223.3 and J223.8 equally well, indicating that carbohydrate
recognition of the Le antigens is the major determinant of
the binding of H. pylori to DCs (Fig. 5 B). Specificity of
DC-SIGN for Lex/y  H. pylori was confirmed by the bind-
ing of J223.3 to DC-SIGN–transfected cells (K-SIGN; Fig.
5 D), but not to untransfected K562 cells (not depicted).
Similarly to DCs, the binding of J223.3 to K-SIGN could
be blocked using anti–DC-SIGN antibodies, mannan, or
EGTA, showing that recognition is specific. As was shown
for other ligands (23), J223.3 was internalized rapidly upon
binding to DC-SIGN (not depicted). These results strongly
suggest that DC-SIGN is an important pathogen receptor
for Lex/y  H. pylori on DCs and that bacteria can escape
from recognition by DCs through phase variation, i.e., by
changing their carbohydrate surface structures.
Binding to DC-SIGN Increases the H. pylori–mediated Pro-
duction of IL-10. Recognition of pathogens induces the
up-regulation of costimulatory molecules on DCs and the
production of cytokines to optimally induce protective T
cell responses. DC-derived cytokines, especially IL-12, in
combination with the interacting pathogen and cellular mi-
croenvironment, determine the differentiation of naive Th
cells into Th1 or Th2 cells (38). To study the role of H. py-
lori–DC-SIGN interaction in the activation of DCs, these
cells were cocultured with J223.3 or J223.8, and their phe-
notype and production of cytokines were analyzed. Both
bacterial strains induced equal maturation, as assessed by
expression of costimulatory molecules and maturation mark-
ers (not depicted). Moreover, blocking the binding of
J223.3 to DC-SIGN did not change the maturation state of
the DCs, indicating that DC-SIGN is not involved in mat-
uration (not depicted). Other receptors, such as Toll-like
receptor (TLR), which recognize distinct structures on
pathogens and trigger DCs (39), might play a role in the
observed DC maturation.
Analysis of the production of cytokines by DCs acti-
vated by the phase variants showed that the binding of H.
pylori to DC-SIGN induces increased production of IL-10
at all MOIs tested. Strikingly, blocking the binding of
J223.3 to DC-SIGN decreased the levels of IL-10 to ap-
proximately those induced by the non–DC-SIGN binder
J223.8 (Fig. 6 A). Increased gastric mucosal IL-10 produc-
tion has been reported in patients with chronic H. pylori
infection, and is suggested to be protective, limiting tissue
damage caused by inflammation, or to play a role in H. py-
lori persistence by damping the immune response against
the bacterium (40). In vivo, other H. pylori proteins may
influence DC production of IL-10 and IL-12 (41). Such
Figure 5. DC-SIGN is expressed
on gastric DCs and is the major re-
ceptor for Le  H. pylori. (A) A tissue
section of stomach was fixed and
stained with anti–DC-SIGN anti-
bodies. A magnification of 20. Arrows
indicate DC-SIGN  DC-like cells in
the lamina propria. (B–D) Monocyte-
derived DCs and RAW 264 macro-
phages (B), monocyte-derived DCs
(C), or K-562 cells transfected with
DC-SIGN (D) were incubated with
FITC-labeled  H. pylori J223.3 or
J223.8, and binding was analyzed
using flow cytometry. In C and D,
cells were preincubated with anti–
DC-SIGN antibodies, mannan,
EDTA, or anti-MR antibodies. One
representative out of four experi-
ments is shown.Bergman et al. 985
proteins, however, are not likely to affect the cytokine
production induced by the DC-SIGN binding and non-
binding bacteria, respectively, because we used isogenic
phase variants of H. pylori that only differ in their Le ex-
pression. We observed no differences in IL-6 production
that was produced in high amounts after challenge with
DC-SIGN– and non–DC-SIGN–binding variants (not
depicted). Although IL-12p40 was produced in our cul-
tures (not depicted), no IL-12p70 could be detected. This
could require additional activation of DCs by CD40 liga-
tion, as occurs during interactions with T cells. Therefore,
we mimicked the engagement by T cells by coculturing
DCs with CD40L-transfected cells and measured IL-
12p70 production. As shown in Fig. 6 B, no differences in
secretion of bioactive IL-12 were observed upon DC acti-
vation by the two variants of H. pylori, not even in the
presence of IFN- .
Binding of H. pylori to DC-SIGN Reduces Th1 Cell Induc-
tion of Naive T Cells by DCs. The cytokine profile of DCs
that interacted with H. pylori through DC-SIGN did not
demonstrate a specific polarization. In vivo, immature DCs
encounter H. pylori at the mucosal surface and transport
bacteria to lymph nodes for subsequent activation and dif-
ferentiation of T cells. To mimic this, we primed DCs with
either one of the H. pylori Le antigenic variants and subse-
quently cocultured washed DCs with naive T cells to ana-
lyze Th cell differentiation. The Th1/Th2 cell profiles of
the resulting Th cells were assessed by measurement of in-
tracellular IL-4 and IFN-  production in individual T cells.
Surprisingly, although J223.8-primed DCs gave rise to
IFN- –producing Th cells, J223.3-primed DCs induced
only low numbers of IL-4– and IFN- –producing Th cells
(Fig. 7 A). This block of Th1 cell induction by DC-SIGN
binding H. pylori was observed in most donors tested and
was sometimes even accompanied by Th2 cell priming
(Fig. 7 B, top). Strikingly, blocking the binding of J223.3
to DC-SIGN using specific antibodies resulted in a de-
creased percentage of IL-4–producing cells and an in-
creased number of IFN- –producing Th cells (Fig. 7 B).
Thus, prevention of J223.3 binding to DC-SIGN resulted
in a shift from a mixed Th1/Th2 cell development to po-
larization of naive T cells toward a Th1 cell phenotype. As
a control, we have added anti–DC-SIGN antibodies to
other DC stimuli such as Escherichia coli LPS, showing that
anti–DC-SIGN antibodies did not have an effect on skew-
ing (not depicted). Our results indicate that recognition of
Le antigens on H. pylori by DC-SIGN blocks the induction
of a Th1 cell response and that phase variation modifies the
Th cell polarization by DCs.
Ex Vivo Challenge with DC-SIGN–binding H. pylori Re-
duces IL-6 Production in Gastric Biopsies. In our experi-
ments so far, we used monocyte-derived DCs. These DCs
might differ from DC-SIGN  DCs in the stomach in their
response to H. pylori. To mimic more closely the in vivo
encounter with H. pylori, gastric biopsies were cocultured
with DC-SIGN–binding or –nonbinding variants and su-
pernatants, as well as homogenates that were analyzed for
cytokine production. No cytokines were detected in the
homogenates (not depicted). However, in most superna-
tants, low levels of IL-12p70 were detected, indicating that
DCs were present in almost all biopsies (not depicted). In
most patients, no significant differences were observed be-
tween the amounts of IL-12p70 produced upon challenge
with either one of the variants of J223, consistent with our
results with isolated DCs. No IL-10 production could be
detected, nor secretion of IL-4 or IFN- , which is in
agreement with previous reports (42). In contrast, when
IL-6 was analyzed, in seven out of nine patients (patient
numbers 3–9) higher levels of IL-6 were produced upon
coculture with nonbinding H. pylori, as compared with
DC-SIGN–binding bacteria (Fig. 8). The reason(s) for the
higher IL-6 production of patients 1 and 2 in the presence
of nonbinding H. pylori is unclear, but it may include host
variability. Alternatively, in patient 1 a relapse of ulcerative
colitis (3 mo before our study) might underlie the observed
IL-6 response in this patient. In conclusion, DCs in gastric
biopsies are activated by H. pylori ex vivo and DC-SIGN–
binding variants induce reduced amounts of IL-6. Lower
levels of IL-6 render T cells more sensitive to suppression
(43), which implies that by targeting DC-SIGN, H. pylori
can decrease T cell activation.
Figure 6. Binding of H. pylori induces DC-SIGN–dependent increase
of IL-10. (A) DCs were incubated with H. pylori J223.3 or J223.8 at an
MOI of 20 in the presence or absence of anti–DC-SIGN antibodies for
1 h, washed, and cultured for 20 h. Supernatant was harvested and the
amount of IL-10 was analyzed by ELISA. (B) Upon coculture of DCs
with H. pylori J223.3 or J223.8, cells were incubated with CD40L-transfected
J558 fibroblasts in the absence or presence of IFN-  for 24 h. Supernatant
was harvested and the amount of IL-12p70 was analyzed by ELISA. One
representative experiment out of four is shown.H. pylori Phase Variants Inhibit Th1 Cell Responses through DC-SIGN 986
Discussion
The mechanisms by which H. pylori is able to persistently
colonize half the population are unknown. Worldwide, H.
pylori strains express LPS Le antigens and Le expression is
subject to phase variation (44). Here, we demonstrate that
H. pylori phase variation occurs in vivo and that H. pylori
expressing monomeric forms of Le antigens specifically tar-
get the C-type lectin DC-SIGN on DCs. This interaction
induces inhibition of Th1 cell differentiation, as compared
with nonbinding phase variants. This is the first study that
shows interactions between H. pylori and its natural host on
the level of individual LPS phase variants derived from a
single clinically isolated strain. Our data implicate for the
first time a role for Le antigen expression and LPS phase
variation in modulation of the host immune response that
operates via the C-type lectin DC-SIGN.
H. pylori adds to the growing list of pathogens that are
bound by DC-SIGN via common pathogen recognition
patterns consisting of high mannose and/or Le carbohy-
drates (24–28, 34). Interestingly, several of these pathogens
target DC-SIGN to modulate DC functions and escape im-
mune activation (45). HIV uses DC-SIGN to target and in-
ternalize into DCs, but escapes antigen-processing routes to
infect T cells (24). Recently, it has been demonstrated that
the mycobacterial component ManLAM binds to DC-
SIGN, subsequently suppressing TLR-4–mediated DC mat-
uration and promoting IL-10 secretion by DCs (27). Here,
we show that H. pylori targets to DC-SIGN by phase varia-
tion in its LPS. H. pylori–expressing Ley or short chains of
Lex (monomeric Lex up to (Lex)4), but not polymeric Lex,
are able to bind DC-SIGN. Therefore, it is the ability to
bind DC-SIGN, rather than the expression of Le antigens,
that enables H. pylori to modulate the immune response.
Distinct from ManLAM occupation of DC-SIGN, H.
pylori did not change DC maturation, but production of
IL-10 was increased (Fig. 6 A). Surprisingly, when analyz-
ing naive T cell differentiation, the Le-containing H. pylori
variants alter the T cell–differentiating capacity of DCs and
block Th1 cell polarization, particularly by binding to DC-
SIGN, resulting in a mixed Th1/Th2 cell response (Fig. 7).
Interestingly, phase variants of H. pylori that have switched
off fucosyltransferase FutB, resulting in loss of Le-contain-
ing determinants on their LPS, escape binding to DC-
Figure 7. Binding of H. pylori to DC-SIGN blocks
skewing of naive T cells to Th1 cells. After preincubation
with anti–DC-SIGN antibodies, DCs were incubated with
H. pylori J223.3 or J223.8 at an MOI of 10 for 48 h,
washed, and then cocultured with highly purified
CD45RA  CD4  T cells. Quiescent T cells were restimu-
lated with PMA and ionomycin, and IL-4 and IFN-  was
analyzed on a single cell basis by intracellular flow cytometry.
Data from two representative donors (A and B/C) are
shown from nine independent experiments.
Figure 8. Ex vivo challenge with DC-SIGN–binding H. pylori induces
lower expression of IL-6 in stomach biopsies. Gastric biopsies were cocul-
tured with 10   106 H. pylori J223.3 or J223.8 for 48 h and supernatants
were harvested for analysis of cytokines, as indicated in Materials and
Methods, by ELISA.Bergman et al. 987
SIGN and induce a strong Th1 cell response. It is likely
that in addition to H. pylori, other pathogens that target
DC-SIGN also induce a shift in the Th1/Th2 cell balance.
Interestingly, Schistosoma mansoni and Leishmania mexicana
that also bind DC-SIGN both favor Th2, and not Th1, cell
responses for chronic infections (34, 45).
To extend our in vitro data on monocyte-derived DCs
and mimic the in vivo challenge of stomach DCs with H.
pylori, stomach biopsies were used in which DC-SIGN was
found to be expressed (Fig. 5 A). In addition, upon incuba-
tion of biopsies with bacteria, IL-12p70 was produced, in-
dicating that DCs were indeed present. Clearly, stomach
lamina propria DCs differ from monocyte-derived DCs in
their cytokine profiles upon H. pylori encounter because no
IL-10 could be detected. This finding seems to contradict a
previously reported increase in gastric mucosal secretion of
IL-10 in patients with H. pylori  chronic inflammation
(40). However, the proposed sources of IL-10 in that
study, i.e., mononuclear phagocytes or lymphocytes, are
absent in H. pylori  gastric mucosa. Instead, in supernatants
of ex vivo–challenged biopsies, IL-6 production was read-
ily detected.
IL-6 is a proinflammatory cytokine that can be produced
by DCs and many other cell types. In our ex vivo system, it
cannot be determined which cells are responsible for IL-6
production, but interestingly, DC-SIGN binding by H. py-
lori reduced the amounts of IL-6 produced compared with
the nonbinding variants. Although interaction between H.
pylori LPS and selectins expressed on the vascular endothe-
lium (46) may influence cytokine production, our results
indicate that DCs, and more specifically DC-SIGN on
DCs, are directly or indirectly involved in suppressing IL-6
secretion. Future studies challenging ex vivo biopsies in the
presence of blocking anti–DC-SIGN antibodies combined
with more sensitive cytokine detection methods, may re-
veal whether host receptors other than DC-SIGN are in-
volved in immune modulation by H. pylori Le antigens.
Recently, IL-6 produced by TLR-activated antigen-
presenting cells was shown to render T cells insensitive to
suppression by regulatory T cells (T reg cells; 43). CD4 
CD25  T reg cells have been shown to reduce immunopa-
thology in H. pylori infection in mice by reducing the acti-
vation of Th1 cells (47). In our system, this would imply
that upon binding to DC-SIGN in vivo, lower levels of
IL-6 are produced, leading to increased T cell sensitivity to
suppression. Although interesting, involvement of T reg
cells in the clinical outcome of H. pylori infection in hu-
mans and the possible effect of bacterial Le phase variation
on T reg cell function warrants further study. Further in-
sight in the role of DC-SIGN in gastric pathology could be
obtained in the future by comparing DC-SIGN binding
capacity of the H. pylori strain(s) isolated, with disease se-
verity by histological analysis (Sidney grading).
Pathogens are recognized by distinct classes of innate im-
mune receptors and the combination of receptors triggered
will determine the functional outcome on DCs. Several re-
cent studies have demonstrated that cross-talk between
C-type lectins and TLRs can occur (27, 48–50). Upon si-
multaneous recognition of zymosan by TLR-2 and the
C-type lectin dectin-1, IL-12 and TNF-  production by DCs
is induced by collaborative signaling of these two pathogen
receptors (49). In contrast, upon binding of ManLAM, both
DC-SIGN and MR deliver a negative signal that interferes
with TLR-mediated DC maturation and IL-12 production
(27, 48). Interestingly, a recent study has shown that binding
of certain ligands to the MR can inhibit DC maturation and
induce T reg cells, whereas other ligands failed to change
DC functions (51). Thus, it would be of interest to study the
role of the MR upon interaction with Le-expressing H. py-
lori; however, this falls outside the scope of this paper. Be-
cause intact H. pylori activates TLR-2 as well as TLR-4 (un-
published data), it is likely that these receptors mediate the
observed DC maturation and cytokine induction. Our re-
sults indicate that H. pylori occupation of DC-SIGN modu-
lates TLR-mediated activation of DCs, leading to a suppres-
sion of Th1 cell differentiation. Direct signal transduction
upon ligand binding to DC-SIGN has not been proven yet,
although the presence of an intracellular ITAM motif simi-
larly to dectin-1 (52) implies that DC-SIGN is a signaling
receptor. To date, DC-SIGN is the only C-type lectin ex-
pressed by DCs that recognizes Le antigens. The H. pylori
phase variants used here that are completely identical except
for Le carbohydrates would be instrumental to analyze inter-
ference of TLR signals by DC-SIGN in DCs.
Successful colonization by H. pylori requires a certain
Th1/Th2 cell balance, which is determined by the genetic
composition of the host (53). Panthel et al. (53) assessed the
ability of H. pylori to colonize BALB/c (intrinsic Th2 cell
responders) and C57BL/6J (an intrinsic Th1 cell responsive
strain) wild-type mice, as compared with their IL-4 and IL-
12 knockouts. Although disruption of IL-12 in BALB/c
mice resulted in enhanced colonization, disruption of IL-4
in these mice has little effect. In contrast, colonization of
C57BL/6J knockout mice deficient in either IL-4 or IL-12
was decreased. These findings support the idea that H. py-
lori would benefit from a mechanism to modulate the host
Th1/Th2 cell balance during colonization, e.g., by phase-
variable interaction with DC-SIGN, leading to suppression
of Th1 cell responses, as we show here. The genetically
very diverse human population might be considered one
broad spectrum of potential hosts, in which individuals dif-
fer in their capacity to produce Th1 and Th2 cell cyto-
kines, and the opposite ends of this spectrum are resembled
by the murine C57BL/6J and the BALB/c genotypes, re-
spectively. Our results suggest that H. pylori may suppress
the local Th1 cell response through Le phase variation and
thereby may create microenvironmental niches (53) with
different Th1/Th2 cell balances within the stomach of a
single host. In vivo, phase variation occurs within the hu-
man stomach (our results). By mechanisms that are still un-
known, the host may positively select for the (mixture of)
phase variants that meet the required Th1/Th2 cell balance
for colonization of that particular host, resulting in selective
outgrowth of one variant and persistent colonization.
Data on acute H. pylori infection are scarce, but in rhesus
macaques acute H. pylori infection leads to a predominantH. pylori Phase Variants Inhibit Th1 Cell Responses through DC-SIGN 988
Th1 cell response (21), which is concordant with the Th1
cell response found in association with gastric pathology in
H. pylori–infected patients (54, 55). However, 80–90% of
H. pylori–infected human individuals will never have symp-
toms (20). Although in humans peptic ulceration is associ-
ated with H. pylori–specific, local gastric predominant Th1
cell responses, the majority of gastric T cell clones reactive
to H. pylori antigens in asymptomatic chronic gastritis are of
the Th0 cell phenotype, secreting both Th1 and Th2 cell
cytokines (56). What host genetic factors are involved in
the shift from acute Th1 cell to a mixed Th1/Th2 cell re-
sponse in chronic asymptomatic gastritis are currently un-
known, leaving challenging topics for future research.
In conclusion, we demonstrated that H. pylori targets
DC-SIGN to block a polarized Th1 cell response by phase-
variable expression of Le antigens. Our results suggest a
new and likely universal role for Le antigen expression and
phase variation by H. pylori, and may help to explain the
success of this pathogen to persistently colonize a large va-
riety of genetically polymorphic hosts worldwide.
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